Type I Collagen Limits VEGFR-2 Signaling by a SHP2 Protein-Tyrosine Phosphatase–Dependent Mechanism 1
- 6 January 2006
- journal article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 98 (1), 45-54
- https://doi.org/10.1161/01.res.0000199355.32422.7b
Abstract
During angiogenesis, a combined action between newly secreted extracellular matrix proteins and the repertoire of integrins expressed by endothelial cells contributes in the regulation of their biological functions. Extracellular matrix-engaged integrins influence tyrosine kinase receptors, thus promoting a regulatory cross-talk between adhesive and soluble stimuli. For instance, vitronectin has been reported to positively regulate VEGFR-2. Here, we show that collagen I downregulates VEGF-A–mediated VEGFR-2 activation. This activity requires the tyrosine phosphatase SHP2, which is recruited to the activated VEGFR-2 when cells are plated on collagen I, but not on vitronectin. Constitutive expression of SHP2C459S mutant inhibits the negative role of collagen I on VEGFR-2 phosphorylation. VEGFR-2 undergoes internalisation, which is associated with dynamin II phosphorylation. Expression of SHP2C459S impairs receptor internalisation suggesting that SHP2-dependent dephosphorylation regulates this process. These findings demonstrate that collagen I in provisional extracellular matrix surrounding nascent capillaries triggers a signaling pathway that negatively regulates angiogenesis.Keywords
This publication has 61 references indexed in Scilit:
- Functional structure and composition of the extracellular matrixThe Journal of Pathology, 2003
- TIMP-2 Mediated Inhibition of AngiogenesisCell, 2003
- Basement membranes: structure, assembly and role in tumour angiogenesisNature Reviews Cancer, 2003
- Molecular regulation of vessel maturationNature Medicine, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Growth factor–induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagenBlood, 2001
- Regulation of Angiogenesis in Vivo by Ligation of Integrin α5β1 with the Central Cell-Binding Domain of FibronectinThe American Journal of Pathology, 2000
- Definition of Two Angiogenic Pathways by Distinct α v IntegrinsScience, 1995
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1Science, 1994